(Q79255327)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14600790%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14600790%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0429-0

29 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0429-0

29 March 2024

author name string

Peter Hersey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14600790%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Tam Nguyen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14600790%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Chitra DeSilva

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14600790%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Margaret Lett

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14600790%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Scott W. Menzies

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600790

29 March 2024

Gary M. Halliday

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600790

29 March 2024

Margaret L. Farrelly

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600790

29 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14600790

29 March 2024

publication date

5 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14600790%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

20 December 2019

http://link.springer.com/content/pdf/10.1007/s00262-003-0429-0.pdf

file format

Portable Document Format

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1007/S00262-003-0429-0

http://link.springer.com/article/10.1007/s00262-003-0429-0/fulltext.html

29 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00262-003-0429-0

http://link.springer.com/content/pdf/10.1007/s00262-003-0429-0

29 March 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1007/S00262-003-0429-0

Cancer Immunology, Immunotherapy

29 March 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14600790%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14600790%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14600790%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

125-134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14600790%20AND%20SRC:MED&resulttype=core&format=json